REVIVE-ing a Weak Heart — Details Matter
Ischemic cardiomyopathy represents the pathophysiological convergence of two growing clinical problems: atherosclerotic coronary artery disease and congestive heart failure. When a patient presents with congestive heart failure, it is incumbent on clinicians to undertake an etiologic workup that inc...
Uloženo v:
| Vydáno v: | The New England journal of medicine Ročník 387; číslo 15; s. 1426 - 1427 |
|---|---|
| Hlavní autor: | |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Boston
Massachusetts Medical Society
13.10.2022
|
| Témata: | |
| ISSN: | 0028-4793, 1533-4406, 1533-4406 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Shrnutí: | Ischemic cardiomyopathy represents the pathophysiological convergence of two growing clinical problems: atherosclerotic coronary artery disease and congestive heart failure. When a patient presents with congestive heart failure, it is incumbent on clinicians to undertake an etiologic workup that includes evaluation for a diagnosis of coronary artery disease
1
; simply establishing a diagnosis of coronary artery disease has been associated with greater use of guideline-directed medical therapies among patients with congestive heart failure.
2
When it is severe, coronary artery disease is often assumed to be the cause of left ventricular dysfunction. Apart from the accuracy of that assumption, a further open question . . . |
|---|---|
| Bibliografie: | SourceType-Scholarly Journals-1 content type line 14 ObjectType-Editorial-2 ObjectType-Commentary-1 content type line 23 |
| ISSN: | 0028-4793 1533-4406 1533-4406 |
| DOI: | 10.1056/NEJMe2210183 |